SPY766.94−0.57%QQQ737.68−0.92%BTC/USD83,698.99−0.88%DIA514.90−0.50%GLD378.65−3.75%TLT78.44−1.11%
Benzinga

Harrow Inc (HROW) Stock Price, Quote, News & History

HROWNASDAQ
Trade with Public
Trade with Public
$31.80
-1.27-3.83%
Last update: Sep 28, 12:46 PM
OverviewNewsEarnings ForecastEventsPrice TargetsFinancialsSentimentOwnershipCompareOptionsStock Report

Harrow (HROW) Stock Price, Quote, News & History | Benzinga

Key Statistics

Open
$32.61
Close
-
Volume / Avg.
493.98K / 585.48K
Day Range
$30.19 - $32.80
52 Wk Range
28.54 - 54.85
Market Cap
$1.19B
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
30
Short Interest
22.23%
Days to Cover
15.68

Recent Harrow, Inc. News

Biotech ETF XBI Hits an Interest Rate Wall as 40+ Catalysts Approach

B. Riley sees 40+ biotech catalysts ahead as rising rates pressure XBI, setting up a key test for the sector during the Q3 2026 earnings season.
Chandrima Sanyal

Harrow’s Iheezo Cuts Eye-Injection Discomfort by More Than Half

Harrow (NASDAQ: HROW) posts positive study results for IHEEZO ophthalmic gel, significantly reducing IVT injection patient discomfort.
Vandana Singh

OppFi Posts Downbeat Q2 Earnings, Joins Upwork, Rocket Lab And Other Big Stocks Moving Lower In Tuesday’s Pre-Market Session

U.S. stock futures mostly lower. OppFi (OPFI) shares fall after missing Q2 earnings and cutting FY26 guidance. Other stocks also down in pre-market.
Avi Kapoor

Viatris Sharpens Focus with Divestiture, Hikes 2026 Outlook

Viatris sells Tyrvaya to Harrow for up to $100 million, raises 2026 guidance after second-quarter earnings and revenue beat estimates.
Vandana Singh

Harrow Adds Another Piece To Ophthalmology Strategy

Harrow relaunches Verkazia for VKC treatment, targeting pediatric eye disease with a steroid-sparing therapy option.
Vandana Singh

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
6.25M
Investing Cash Flow (TTM)
-23.69M
Financing Cash Flow (TTM)
48.37M
Free Cash Flow (TTM)
-13.08M
Capital Expenditure (TTM)
-19.33M
Net Change in Cash (TTM)
30.93M

Analyst Trends and Forecast

2
Apr
2
May
1
Jul
1
Aug
1
Sep
Buy
Hold
Sell
Strong Sell

Analyst Rating and Forecast

12345
4.1
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Valuation Metrics

Enterprise Value
$1.46B
PE Ratio (TTM)
-
PE Ratio (FWD)
45.87
PEG Ratio (TTM)
-
PS Ratio (TTM)
4.47
PB Ratio (TTM)
81.56
Earnings Yield % (TTM)
-2.99%
Earnings Yield % (FWD)
2.18%
EV / EBITDA (TTM)
128.01
Price / EBITDA (TTM)
108.27
Price / Free Cash Flow (TTM)
-
Book Value / Share
$0.41

Company Debt

Total Debt
$292.38M
LT Debt
$292.38M
LT Debt Issuance (TTM)
-
LT Debt Repayment (TTM)
-
Total Cash
$83.89M
Debt to Equity
19.79
Issuance of Debt (TTM)
-
Repayment of Debt (TTM)
-

Key Statistics

Open
$32.61
Close
-
Volume / Avg.
493.98K / 585.48K
Day Range
$30.19 - $32.80
52 Wk Range
28.54 - 54.85
Market Cap
$1.19B
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
30
Short Interest
22.23%
Days to Cover
15.68

About

Sector
Health Care
Industry
Pharmaceuticals
Harrow Inc is an eyecare pharmaceutical company engaged in the discovery, development, and commercialization of ophthalmic pharmaceutical products for the U.S. market. The company partners with U.S. eyecare professionals to develop products used to m...
Show More
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

FAQ

Q

How do I buy Harrow (HROW) stock?

A

You can purchase shares of Harrow (NASDAQ:HROW) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Harrow (HROW) competitors?

Q

What is the forecast, or price target, for Harrow (HROW) stock?

A

Harrow has a consensus price target of $60.18.

Q

What is the current price for Harrow (HROW)?

A

The stock price for Harrow (NASDAQ: HROW) is $31.805 last updated September 28, 2026 at 12:46 PM EDT.

Q

Does Harrow (HROW) pay a dividend?

A

There are no upcoming dividends for Harrow.

Q

When is Harrow (NASDAQ:HROW) reporting earnings?

A

Harrow does not have any upcoming earnings scheduled.

Q

Is Harrow (HROW) going to split?

A

There is no upcoming split for Harrow.

Q

What sector and industry does Harrow (HROW) operate in?

A

Harrow is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

Data & APIs: Benzinga APIs · Stock News API · Analyst Ratings API · Company Logo API

Market data provided by Benzinga APIs

Connect With Us
instagramlinkedinyoutubeblueskymastodon
About Benzinga
Market Resources
Trading Tools & Education
Ring the Bell
© 2026 Benzinga | All Rights Reserved